CERES INC. Logo

CERES INC.

Develops online media platforms connecting consumers with advertisers through a rewards system.

3696 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
渋谷区桜丘町1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ceres Inc. is an internet marketing company operating under the mission of "Enriching the world through internet marketing." The company's core business involves the development and management of online media platforms. Its flagship service is "Moppy," a point media site where users can accumulate points through various online activities and exchange them for rewards. By connecting a large consumer base with advertisers, Ceres provides marketing and user acquisition solutions for businesses while offering value to its platform users.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 05:30
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-08-13 05:29
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 228.9 KB
2025-07-18 08:49
M&A Activity
臨時報告書
Japanese 22.5 KB
2025-07-01 08:56
Major Shareholding Notification
大量保有報告書
Japanese 34.4 KB
2025-05-08 09:40
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2025-04-21 09:17
Share Issue/Capital Change
臨時報告書
Japanese 30.8 KB
2025-03-26 06:24
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.2 KB
2025-03-26 06:18
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 06:10
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-03-26 05:15
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 18.0 KB
2025-01-27 09:12
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2024-08-13 08:58
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-08-13 08:57
Interim Report
半期報告書-第20期(2024/01/01-2024/12/31)
Japanese 197.3 KB

Automate Your Workflow. Get a real-time feed of all CERES INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CERES INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye PCILT
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan 7066
PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan 4587
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden PHAL
Pharos iBio Co., Ltd. Logo
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea 388870
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan 6190
P&K Skin Research Center Co.,Ltd. Logo
Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.
South Korea 347740
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL

Talk to a Data Expert

Have a question? We'll get back to you promptly.